Metipranolol Hydrochloride

CHEMBL1200947 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
345.9 g/mol
LogP
Phase
4

A salt form of metipranolol, sharing the same therapeutic uses.

Masse moléculaire

345,9000 g/mol

TPSA

67,80 Ų

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CC(=O)Oc1c(C)cc(OCC(O)CNC(C)C)c(C)c1C.Cl

InChI

InChI=1S/C17H27NO4.ClH/c1-10(2)18-8-15(20)9-21-16-7-11(3)17(22-14(6)19)13(5)12(16)4;/h7,10,15,18,20H,8-9H2,1-6H3;1H

Molecular Formula

C17H28ClNO4

HBD / HBA

3 / 5

Liaisons Rotatives

8

Atomes Lourds

23

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

A salt form of metipranolol, sharing the same therapeutic uses.

Yes, Metipranolol Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200947. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 656682. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.